CUTANEOUS BLASTOMYCOSIS

CUTANEOUS BLASTOMYCOSIS was reported 40 times

CUTANEOUS BLASTOMYCOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Selective T Cell Costimulation Blocker [EPC] 3 0.0006
1 Antimetabolite Immunosuppressant [EPC] 6 0.0003
2 Lipid-based Polyene Antifungal [EPC] 1 0.0001
3 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
4 Polyene Antifungal [EPC] 1 0.0000
5 Corticosteroid [EPC] 31 0.0000
6 Azole Antifungal [EPC] 2 0.0000
7 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
8 Kinase Inhibitor [EPC] 1 0.0000